お知らせ • Feb 17
CPT Global Limited Announces Resignation of Deborah Hadwen as Non-Executive Director and Chair of Audit & Risk Committee, Effective February 16, 2026 CPT Global Limited announced that Deborah Hadwen has resigned from the Board as Non-Executive Director and Chair of the Audit & Risk Committee with effect from February 16, 2026. Deborah Hadwen served as a Non-Executive Director and Chair of the Audit & Risk Committee. Deborah’s contribution to the Board, the Audit & Risk Committee and the Company during her appointment as Non-Executive Director has been significant. お知らせ • Oct 14
CPT Global Limited, Annual General Meeting, Nov 14, 2025 CPT Global Limited, Annual General Meeting, Nov 14, 2025. Location: at the office of cpt global limited, level 3, 818 bourke street, docklands, victoria 3008, Australia お知らせ • Oct 18
CPT Global Limited, Annual General Meeting, Nov 20, 2024 CPT Global Limited, Annual General Meeting, Nov 20, 2024. Location: at the office of cpt global limited, level 3, 818 bourke street, docklands, victoria 3008, Australia Buy Or Sell Opportunity • Oct 11
Now 29% undervalued Over the last 90 days, the stock has risen 19% to €0.035. The fair value is estimated to be €0.049, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 14% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Oct 01
Full year 2024 earnings released: AU$0.038 loss per share (vs AU$0.049 loss in FY 2023) Full year 2024 results: AU$0.038 loss per share (improved from AU$0.049 loss in FY 2023). Revenue: AU$20.7m (down 26% from FY 2023). Net loss: AU$1.59m (loss narrowed 23% from FY 2023). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 56 percentage points per year, which is a significant difference in performance. Buy Or Sell Opportunity • Sep 27
Now 24% undervalued after recent price drop Over the last 90 days, the stock has fallen 29% to €0.02. The fair value is estimated to be €0.026, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 14% over the last 3 years. Meanwhile, the company became loss making. Buy Or Sell Opportunity • Sep 10
Now 26% undervalued after recent price drop Over the last 90 days, the stock has fallen 62% to €0.018. The fair value is estimated to be €0.025, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 14% over the last 3 years. Meanwhile, the company became loss making. Reported Earnings • Sep 01
Full year 2024 earnings released: AU$2.95 loss per share (vs AU$0.049 loss in FY 2023) Full year 2024 results: AU$2.95 loss per share. Revenue: AU$20.7m (down 26% from FY 2023). Net loss: AU$1.23m (loss narrowed 40% from FY 2023). お知らせ • May 08
CPT Global Limited Appoints Gerry Tuddenham as Head of APAC CPT Global Limited announced that effective immediately, Founder and Executive Director Gerry Tuddenham, will be resuming the local leadership of CPT Global's APAC business. Gerry will split his 3 days per week across existing responsibilities as well as steering operations in the APAC market, supported by experienced executive team. This will provide me with the bandwidth to focus on exploring growth prospects in the northern region to strategically position the company for continued success on a global front. お知らせ • Feb 29
CPT Global Limited Announces Executive Changes CPT Global Limited announce the appointment of Nathan Marburg as Company Secretary. Mark Licciardo of Acclime Corporate Services has resigned as Company Secretary with effect from 29 February 2024. CPT Global further advises, in accordance with Listing Rule 12.6, that Nathan is now the person responsible for communications with ASX in relation to ASX Listing Rule matters. New Risk • Feb 29
New major risk - Revenue and earnings growth Earnings have declined by 3.8% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (31% average weekly change). Earnings have declined by 3.8% per year over the past 5 years. Market cap is less than US$10m (€2.64m market cap, or US$2.86m). お知らせ • Oct 25
CPT Global Limited Announces Management Changes CPT Global Limited announced that Mr. Fred Grimwade will retire as Chairman and as a Non-Executive Director, effective immediately following the CPT Global 2023 Annual General Meeting to be held on Wednesday 22 November 2023. Mr. Steve Targett, who joined the Board on 24 January 2023, will become Chairman of the CPT Global Board effective from 22 November 2023. Mr. Targett’s appointment to the CPT Global Board was announced on 24 January 2023. Mr. Targett is an experienced Chair, Director, CEO and Executive across the banking and financial services sectors including executive roles over seven years heading the wholesale banking divisions of NAB, Lloyds Bank and ANZ. In addition to his Non-Executive Chairman’s and Director role at Pioneer Credit Limited, Mr. Targett serves as Chair of P&N Bank Group (having resigned from this role as director and Chairman with effect from 11 December 2023) and his previous Chair and/or directorships include Lloyds Bank in the UK, National Australia Group Europe, National Bank of New Zealand, KVB Wealth Management and Cuscal Limited. Mr. Targett, who is a member of the Australian Institute of Company Directors, was also previously Chairman of the Australian Financial Markets Association and was the only Australian elected to the Board of the New York-based International Swaps and Derivatives Association. お知らせ • Oct 20
CPT Global Limited, Annual General Meeting, Nov 22, 2023 CPT Global Limited, Annual General Meeting, Nov 22, 2023, at 11:01 AUS Eastern Standard Time. Location: Level 3, 818 Bourke Street Docklands Victoria Australia Agenda: To consider the Annual Report, Financial Report and the Reports of the Directors and of the Auditor for the year ended 30 June 2023; to consider adoption of remuneration report; to consider election of Mr. Steve Targett as a director; to consider election of Ms. Deborah Hadwen as a director; to consider grant of performance rights to Mr. Luke Tuddenham for FY 23 and FY 24; to consider approval of the CPT Global Limited Rights Plan. Reported Earnings • Oct 02
Full year 2023 earnings released: AU$0.049 loss per share (vs AU$0.035 profit in FY 2022) Full year 2023 results: AU$0.049 loss per share (down from AU$0.035 profit in FY 2022). Revenue: AU$28.1m (down 6.0% from FY 2022). Net loss: AU$2.06m (down 240% from profit in FY 2022). Reported Earnings • Sep 01
Full year 2023 earnings released: AU$0.049 loss per share (vs AU$0.035 profit in FY 2022) Full year 2023 results: AU$0.049 loss per share (down from AU$0.035 profit in FY 2022). Revenue: AU$28.1m (down 6.0% from FY 2022). Net loss: AU$2.06m (down 240% from profit in FY 2022). Buying Opportunity • Aug 31
Now 37% undervalued after recent price drop Over the last 90 days, the stock is down 59%. The fair value is estimated to be €0.08, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 6.2% over the last 3 years. Meanwhile, the company has become profitable. New Risk • Aug 28
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (17% average weekly change). High level of non-cash earnings (180% accrual ratio). Market cap is less than US$10m (€5.35m market cap, or US$5.78m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Paying a dividend despite having no free cash flows. Profit margins are more than 30% lower than last year (2.8% net profit margin). Board Change • Jul 26
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Non-Executive Chairman Fred Grimwade was the last independent director to join the board, commencing their role in 2004. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.